Synopsis
0
USDMF
0
EU WC
0
NDC API
0
VMF
0
FDA Orange Book
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Coating Systems & Additives
Co-Processed Excipients
Granulation
Direct Compression
Thickeners and Stabilizers
Taste Masking
Controlled & Modified Release
Fillers, Diluents & Binders
Parenteral
Global Sales Information
Finished Drug Prices
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Dosage Form : Ret Tabl
Dosage Strength : 100mg
Price Per Pack (Euro) : 44.85
Published in :
Country : Switzerland
RX/OTC/DISCN : Class A
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Dosage Form : Ret Tabl
Dosage Strength : 10mg
Price Per Pack (Euro) : 8.63
Published in :
Country : Switzerland
RX/OTC/DISCN : Class A
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Dosage Form : Ret Tabl
Dosage Strength : 10mg
Price Per Pack (Euro) : 12.94
Published in :
Country : Switzerland
RX/OTC/DISCN : Class A
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Dosage Form : Ret Tabl
Dosage Strength : 200mg
Price Per Pack (Euro) : 66.28
Published in :
Country : Switzerland
RX/OTC/DISCN : Class A
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Dosage Form : Ret Tabl
Dosage Strength : 30mg
Price Per Pack (Euro) : 15.15
Published in :
Country : Switzerland
RX/OTC/DISCN : Class A
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Dosage Form : Ret Tabl
Dosage Strength : 30mg
Price Per Pack (Euro) : 32.1
Published in :
Country : Switzerland
RX/OTC/DISCN : Class A
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Dosage Form : Ret Tabl
Dosage Strength : 60mg
Price Per Pack (Euro) : 27.26
Published in :
Country : Switzerland
RX/OTC/DISCN : Class A
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Morphine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Morphine Hydrochloride, including repackagers and relabelers. The FDA regulates Morphine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Morphine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Morphine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Morphine Hydrochloride supplier is an individual or a company that provides Morphine Hydrochloride active pharmaceutical ingredient (API) or Morphine Hydrochloride finished formulations upon request. The Morphine Hydrochloride suppliers may include Morphine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Morphine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Morphine Hydrochloride Drug Master File in Japan (Morphine Hydrochloride JDMF) empowers Morphine Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Morphine Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Morphine Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Morphine Hydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Morphine Hydrochloride Drug Master File in Korea (Morphine Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Morphine Hydrochloride. The MFDS reviews the Morphine Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Morphine Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Morphine Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Morphine Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Morphine Hydrochloride suppliers with KDMF on PharmaCompass.
A Morphine Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Morphine Hydrochloride Certificate of Suitability (COS). The purpose of a Morphine Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Morphine Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Morphine Hydrochloride to their clients by showing that a Morphine Hydrochloride CEP has been issued for it. The manufacturer submits a Morphine Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Morphine Hydrochloride CEP holder for the record. Additionally, the data presented in the Morphine Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Morphine Hydrochloride DMF.
A Morphine Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Morphine Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Morphine Hydrochloride suppliers with CEP (COS) on PharmaCompass.
Morphine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Morphine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Morphine Hydrochloride GMP manufacturer or Morphine Hydrochloride GMP API supplier for your needs.
A Morphine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Morphine Hydrochloride's compliance with Morphine Hydrochloride specifications and serves as a tool for batch-level quality control.
Morphine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Morphine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Morphine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Morphine Hydrochloride EP), Morphine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Morphine Hydrochloride USP).
LOOKING FOR A SUPPLIER?
